Canada Markets closed

Processa Pharmaceuticals, Inc. (PCSA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.84+0.15 (+1.95%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close7.69
Open7.75
Bid7.80 x 800
Ask7.91 x 1300
Day's Range7.65 - 7.91
52 Week Range4.05 - 14.24
Volume27,909
Avg. Volume99,779
Market Cap121.689M
Beta (5Y Monthly)-0.06
PE Ratio (TTM)N/A
EPS (TTM)-2.08
Earnings DateMar. 25, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • GlobeNewswire

    Processa Pharmaceuticals Cleared by FDA to Proceed with Phase 2a Trial for the Treatment of Gastroparesis

    HANOVER, MD, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that they have been cleared by the U.S. Food and Drug Administration (FDA) to proceed with a Phase 2a clinical trial of PCS12852 in patients with moderate to severe gastroparesis, an unmet medical need cond

  • GlobeNewswire

    Processa Pharmaceuticals to Participate in Upcoming Investor Conferences - Update

    HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that management will participate in upcoming investor conferences: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Date and Time: 9/22/2021 9:05 AM (ET)Webcast: https://wsw.com/webcast/oppenheim

  • GlobeNewswire

    Processa Pharmaceuticals to Participate in Upcoming Investor Conferences

    HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that management will participate in upcoming investor conferences: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Date and Time: 9/22/2021 9:05 AM (ET)Webcast: https://wsw.com/webcast/oppenheim